Skip to main content
. 2021 Aug 8;22(4):715. doi: 10.3892/ol.2021.12976

Figure 1.

Figure 1.

Construction of a model of CRPC xenografts. (A) Overview of the formation of the human to mouse xenograft CRPC model. (B) In vivo imaging of the tumor stained with near-infrared fluorescent dye (ProSense 680). (C) Changes of recorded tumor volume. (D) Hematoxylin and eosin staining of histological slide of tumor tissue on the 28th day after tumor recurrence. HNPC, Human prostate cancer; CRPC, castration-resistant prostate cancer.